Potential use of exenatide for the treatment of obesity.
about
Weight loss is still an essential intervention in obesity and its complications: a reviewSynergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents.Neurotransmitters and Neuropeptides: New Players in the Control of Islet of Langerhans' Cell Mass and Function.Co-agonist of glucagon and GLP-1 reduces cholesterol and improves insulin sensitivity independent of its effect on appetite and body weight in diet-induced obese C57 mice.
P2860
Potential use of exenatide for the treatment of obesity.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Potential use of exenatide for the treatment of obesity.
@ast
Potential use of exenatide for the treatment of obesity.
@en
type
label
Potential use of exenatide for the treatment of obesity.
@ast
Potential use of exenatide for the treatment of obesity.
@en
prefLabel
Potential use of exenatide for the treatment of obesity.
@ast
Potential use of exenatide for the treatment of obesity.
@en
P2860
P1476
Potential use of exenatide for the treatment of obesity.
@en
P2093
Rodolfo Guardado Mendoza
P2860
P304
P356
10.1517/13543784.2011.630660
P407
P50
P577
2011-10-24T00:00:00Z